Want to join the conversation?
$Amgen today announced that US FDA has approved a new cholesterol-lowering medication, Repatha (TM) (evolocumab) Injection. Repatha is a human monoclonal antibody that inhibits proprotein convertase subtilisin/kexin type 9 (PCSK9), a protein that reduces liver's ability to remove low-density lipoprotein cholesterol or "bad" cholesterol, from blood.
$NFLX a monster move, going up. Expect making some money on Monday.
$AMD down more than 6% even after posting above consensus third quarter results.
$MCD stock rose more than 2% after it posted better than expected 3Q16 results, driven by global same-store sales growth. Meanwhile, earnings and revenue were lower than last year, hurt by refranchising efforts.